TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer said he would not be surprised if Allergan (AGN - Get Report) looked at buying Anacor (ANAC before Pfizer (PFE - Get Report) decided to acquire the company for $5.2 billion, including debt. Cramer said, 'the area of atopic dermatitis is a crowded field. I think people have to recognize that Pfizer may have decided that we have to buy someone. This is a very unusual acquisition because Pfizer has been building up its cancer franchise.'
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
More from Video
Watch: Jim Cramer Analyzes CAT, CVX, DIS, DWDP, GS, HD, IBM and MCD In Real Time
Have you ever seen someone analyze the 'tape' in real time? See Jim Cramer give his real time stock analysis on companies like Goldman Sachs, Dow Dupont, Caterpillar and more.
Cramer on Comcast, 3M, and Southwest Airlines Earnings Report
Watch the video for Jim Cramer's take on CMCSA, MMM, LUV earnings in under 60 seconds.
Why Tesla's Latest Earnings Report Has Jim Cramer Calling Elon Musk P.T. Barnum
Here's why Elon Musk's latest Tesla earnings call has Jim Cramer thinking about P.T. Barnum.
Cramer: Why Facebook's Potential $3B to 5B FTC Fine Is Like a Library Fee
Another day, another Facebook headline. Jim Cramer says he isn't too worried about Facebook's potential FTC fine after the social media giant reported strong than expected earnings